Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic...

Area of Science:

• Hepatology
• Pharmacology
• Biochemistry

Background:

• Trans-ε-viniferin, a resveratrol dimer from grapevine wood, exhibits protective effects against hepatic steatosis in vivo.
• Poor bioavailability of trans-ε-viniferin limits its therapeutic potential.
• Hepatic steatosis, or fatty liver disease, is a growing health concern requiring novel therapeutic strategies.

Purpose of the Study:

• To investigate the anti-steatotic potential of trans-ε-viniferin and its glucuronide metabolites in an in vitro model of hepatic steatosis.
• To elucidate the mechanisms of action underlying the anti-steatotic effects of these compounds.
• To identify which metabolites contribute to the observed protective effects.

Main Methods:

• Utilized AML-12 cells treated with palmitic acid to model hepatic steatosis.
• Assessed cell viability and triglyceride accumulation upon treatment with trans-ε-viniferin and its glucuronides.
• Employed Real-Time PCR and Western Blot to analyze molecular mechanisms.
• Quantified compound levels in cells and media.

Main Results:

• Trans-ε-viniferin-2-glucuronide demonstrated significant triglyceride-lowering properties.
• This metabolite modulated de novo lipogenesis, fatty acid uptake, and triglyceride assembly.
• Other glucuronide metabolites and parent compound showed varying effects on cell viability and steatosis.
• Successful quantification of compounds within cellular and extracellular environments.

Conclusions:

• Trans-ε-viniferin-2-glucuronide possesses notable anti-steatotic activity by influencing key lipid metabolism pathways.
• Glucuronide metabolites of trans-ε-viniferin are likely responsible for the previously observed in vivo anti-steatotic effects.
• This study highlights the therapeutic potential of trans-ε-viniferin metabolites in managing hepatic steatosis.